Artículos científicos sobre LMC & Covid-19
- Is COVID-19 less severe in CML patients than in those with other haematological cancers?
- COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
- A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic
- Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis
- Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms
- Blurring of vision as the only symptom in an undiagnosed case of chronic myeloid leukemia in the COVID-19 era
- The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
- COVID-19-Induced Pancytopenia in a Major Molecular Response CML Patient on Dasatinib: A Case Report and Review of the Literature. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875585/pdf/2233-1-19580-1-10-20210112.pdf
- Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) without Interruption. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938919/pdf/mjhid-13-1-e2021022.pdf
- Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493657/pdf/fonc-10-01428.pdf
- Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217438/pdf/fpsyt-12-679932.pdf
- Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239833/pdf/BJH-9999-0.pdf
- Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. https://doi.org/10.1177/1078155220953198
- Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey.
- Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study.
- COVID-19 in Persons With Chronic Myeloid Leukaemia
- SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection
- Leucemia Mieloide Crónica & Coronavirus COVID19